Bilobectomy Versus Lobectomy for Non-Small Cell Lung Cancer: A Comparative Study of Outcomes, Long-Term Survival, and Quality of Life

Dong Xie, Claude Deschamps, Robert K. Shen, Bo Deng, Jason A. Wampfler, Stephen D. Cassivi, Francis C. Nichols, Mark S. Allen, Dennis A Wigle, Ping Yang

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Background We aimed to compare long-term survival and quality of life (QOL) outcomes after bilobectomy and lobectomy for non-small cell lung cancer patients. Methods A cohort of 951 consecutive patients was identified from a single treatment institution, of whom 128 underwent bilobectomy and 823, lobectomy. Propensity score matching (1:3) was applied to balance known confounders between the two surgical groups and resulted in 512 patients (matched cohort). Unmatched and matched analyses were performed to compare clinical outcomes between the two groups, including operative mortality rate, morbidity rate, long-term survival, overall QOL, and specific symptoms. Results Operative mortality was higher in the bilobectomy group than in the lobectomy group (2.3% versus 0.5%, p = 0.022). Morbidity rates did not differ significantly between the two groups in either unmatched or matched cohort. In the unmatched analysis, the overall survival (OS [p = 0.003]) and disease-free survival (DFS [p = 0.003]) were significantly lower in the bilobectomy group; whereas in the matched analysis, no significant difference was found in either OS (p = 0.473) or DFS (p = 0.387). Using multivariate analysis, the operation type was not found to be a significant factor for either OS (hazard ratio 1.18; 95% confidence interval: 0.91 to 1.52; p = 0.22) or DFS (hazard ratio 1.22; 95% confidence interval: 0.95 to 1.58; p = 0.13). Patients who underwent bilobectomy appeared to have similar measures of QOL as lobectomy patients, except for coughing and dyspnea. Conclusions Our findings indicate that patients with non-small cell lung cancer treated with bilobectomy had similar morbidity, OS, DFS, and overall QOL as patients treated with lobectomy, but had higher mortality by matched analysis.

Original languageEnglish (US)
Article number28066
Pages (from-to)242-250
Number of pages9
JournalAnnals of Thoracic Surgery
Volume100
Issue number1
DOIs
StatePublished - Jul 1 2015

Fingerprint

Non-Small Cell Lung Carcinoma
Quality of Life
Outcome Assessment (Health Care)
Survival
Morbidity
Mortality
Confidence Intervals
Propensity Score
Dyspnea
Disease-Free Survival
Multivariate Analysis

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Surgery
  • Pulmonary and Respiratory Medicine

Cite this

Bilobectomy Versus Lobectomy for Non-Small Cell Lung Cancer : A Comparative Study of Outcomes, Long-Term Survival, and Quality of Life. / Xie, Dong; Deschamps, Claude; Shen, Robert K.; Deng, Bo; Wampfler, Jason A.; Cassivi, Stephen D.; Nichols, Francis C.; Allen, Mark S.; Wigle, Dennis A; Yang, Ping.

In: Annals of Thoracic Surgery, Vol. 100, No. 1, 28066, 01.07.2015, p. 242-250.

Research output: Contribution to journalArticle

Xie, Dong ; Deschamps, Claude ; Shen, Robert K. ; Deng, Bo ; Wampfler, Jason A. ; Cassivi, Stephen D. ; Nichols, Francis C. ; Allen, Mark S. ; Wigle, Dennis A ; Yang, Ping. / Bilobectomy Versus Lobectomy for Non-Small Cell Lung Cancer : A Comparative Study of Outcomes, Long-Term Survival, and Quality of Life. In: Annals of Thoracic Surgery. 2015 ; Vol. 100, No. 1. pp. 242-250.
@article{788d921fa494474982ddac7244fd2714,
title = "Bilobectomy Versus Lobectomy for Non-Small Cell Lung Cancer: A Comparative Study of Outcomes, Long-Term Survival, and Quality of Life",
abstract = "Background We aimed to compare long-term survival and quality of life (QOL) outcomes after bilobectomy and lobectomy for non-small cell lung cancer patients. Methods A cohort of 951 consecutive patients was identified from a single treatment institution, of whom 128 underwent bilobectomy and 823, lobectomy. Propensity score matching (1:3) was applied to balance known confounders between the two surgical groups and resulted in 512 patients (matched cohort). Unmatched and matched analyses were performed to compare clinical outcomes between the two groups, including operative mortality rate, morbidity rate, long-term survival, overall QOL, and specific symptoms. Results Operative mortality was higher in the bilobectomy group than in the lobectomy group (2.3{\%} versus 0.5{\%}, p = 0.022). Morbidity rates did not differ significantly between the two groups in either unmatched or matched cohort. In the unmatched analysis, the overall survival (OS [p = 0.003]) and disease-free survival (DFS [p = 0.003]) were significantly lower in the bilobectomy group; whereas in the matched analysis, no significant difference was found in either OS (p = 0.473) or DFS (p = 0.387). Using multivariate analysis, the operation type was not found to be a significant factor for either OS (hazard ratio 1.18; 95{\%} confidence interval: 0.91 to 1.52; p = 0.22) or DFS (hazard ratio 1.22; 95{\%} confidence interval: 0.95 to 1.58; p = 0.13). Patients who underwent bilobectomy appeared to have similar measures of QOL as lobectomy patients, except for coughing and dyspnea. Conclusions Our findings indicate that patients with non-small cell lung cancer treated with bilobectomy had similar morbidity, OS, DFS, and overall QOL as patients treated with lobectomy, but had higher mortality by matched analysis.",
author = "Dong Xie and Claude Deschamps and Shen, {Robert K.} and Bo Deng and Wampfler, {Jason A.} and Cassivi, {Stephen D.} and Nichols, {Francis C.} and Allen, {Mark S.} and Wigle, {Dennis A} and Ping Yang",
year = "2015",
month = "7",
day = "1",
doi = "10.1016/j.athoracsur.2015.03.018",
language = "English (US)",
volume = "100",
pages = "242--250",
journal = "Annals of Thoracic Surgery",
issn = "0003-4975",
publisher = "Elsevier USA",
number = "1",

}

TY - JOUR

T1 - Bilobectomy Versus Lobectomy for Non-Small Cell Lung Cancer

T2 - A Comparative Study of Outcomes, Long-Term Survival, and Quality of Life

AU - Xie, Dong

AU - Deschamps, Claude

AU - Shen, Robert K.

AU - Deng, Bo

AU - Wampfler, Jason A.

AU - Cassivi, Stephen D.

AU - Nichols, Francis C.

AU - Allen, Mark S.

AU - Wigle, Dennis A

AU - Yang, Ping

PY - 2015/7/1

Y1 - 2015/7/1

N2 - Background We aimed to compare long-term survival and quality of life (QOL) outcomes after bilobectomy and lobectomy for non-small cell lung cancer patients. Methods A cohort of 951 consecutive patients was identified from a single treatment institution, of whom 128 underwent bilobectomy and 823, lobectomy. Propensity score matching (1:3) was applied to balance known confounders between the two surgical groups and resulted in 512 patients (matched cohort). Unmatched and matched analyses were performed to compare clinical outcomes between the two groups, including operative mortality rate, morbidity rate, long-term survival, overall QOL, and specific symptoms. Results Operative mortality was higher in the bilobectomy group than in the lobectomy group (2.3% versus 0.5%, p = 0.022). Morbidity rates did not differ significantly between the two groups in either unmatched or matched cohort. In the unmatched analysis, the overall survival (OS [p = 0.003]) and disease-free survival (DFS [p = 0.003]) were significantly lower in the bilobectomy group; whereas in the matched analysis, no significant difference was found in either OS (p = 0.473) or DFS (p = 0.387). Using multivariate analysis, the operation type was not found to be a significant factor for either OS (hazard ratio 1.18; 95% confidence interval: 0.91 to 1.52; p = 0.22) or DFS (hazard ratio 1.22; 95% confidence interval: 0.95 to 1.58; p = 0.13). Patients who underwent bilobectomy appeared to have similar measures of QOL as lobectomy patients, except for coughing and dyspnea. Conclusions Our findings indicate that patients with non-small cell lung cancer treated with bilobectomy had similar morbidity, OS, DFS, and overall QOL as patients treated with lobectomy, but had higher mortality by matched analysis.

AB - Background We aimed to compare long-term survival and quality of life (QOL) outcomes after bilobectomy and lobectomy for non-small cell lung cancer patients. Methods A cohort of 951 consecutive patients was identified from a single treatment institution, of whom 128 underwent bilobectomy and 823, lobectomy. Propensity score matching (1:3) was applied to balance known confounders between the two surgical groups and resulted in 512 patients (matched cohort). Unmatched and matched analyses were performed to compare clinical outcomes between the two groups, including operative mortality rate, morbidity rate, long-term survival, overall QOL, and specific symptoms. Results Operative mortality was higher in the bilobectomy group than in the lobectomy group (2.3% versus 0.5%, p = 0.022). Morbidity rates did not differ significantly between the two groups in either unmatched or matched cohort. In the unmatched analysis, the overall survival (OS [p = 0.003]) and disease-free survival (DFS [p = 0.003]) were significantly lower in the bilobectomy group; whereas in the matched analysis, no significant difference was found in either OS (p = 0.473) or DFS (p = 0.387). Using multivariate analysis, the operation type was not found to be a significant factor for either OS (hazard ratio 1.18; 95% confidence interval: 0.91 to 1.52; p = 0.22) or DFS (hazard ratio 1.22; 95% confidence interval: 0.95 to 1.58; p = 0.13). Patients who underwent bilobectomy appeared to have similar measures of QOL as lobectomy patients, except for coughing and dyspnea. Conclusions Our findings indicate that patients with non-small cell lung cancer treated with bilobectomy had similar morbidity, OS, DFS, and overall QOL as patients treated with lobectomy, but had higher mortality by matched analysis.

UR - http://www.scopus.com/inward/record.url?scp=84933678980&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84933678980&partnerID=8YFLogxK

U2 - 10.1016/j.athoracsur.2015.03.018

DO - 10.1016/j.athoracsur.2015.03.018

M3 - Article

C2 - 26007206

AN - SCOPUS:84933678980

VL - 100

SP - 242

EP - 250

JO - Annals of Thoracic Surgery

JF - Annals of Thoracic Surgery

SN - 0003-4975

IS - 1

M1 - 28066

ER -